| Coley Pharmaceuticals Group |
|
Coley,
in Wellesley, MA, and in Langenfeld, Germany, is developing immunostimulatory molecules, consisting of proprietary DNA sequences that rapidly activate both antibody production and cellular immune responses, for the treatment of cancer, allergy and asthma, and infectious disease.
|